The clinical research industry is currently seeing an unprecedented rise of sites facing financial burden due to increasing costs of staffing and supplies. Now more than ever, it's critical that sites learn what actions they can take to ensure they understand what they are agreeing to in clinical trial agreements and what flexibility they have. Daniel Fox, Ph.D., founder and CEO of the Clinical Research Payment Network, shares what to look for in CTAs to ensure they are in the site's best interest and how to establish a mutual relationship of trust with industry partners.